ArticlePloS one2025
Association between gastrointestinal diseases and osteoarthritis risk based on data from NHANES 2011-2018.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoarthritis (OA) and gastrointestinal diseases are two significant public health problems. However, the association between the two is unclear. This study aimed to investigate the biological relationship between gastrointestinal diseases and OA using data derived from the National Health and Nutrition Examination Survey (NHANES) database. A total of 8,833 participants registered in the NHANES between 2011 and 2018 were enrolled; 5,044 participants were included in the study after excluding ineligible samples. Three models were constructed to investigate the correlation between gastrointestinal diseases and OA. Risk stratification analysis was conducted, and a receiver operating characteristic (ROC) curve was employed. Among 5,044 participants, even after stratification, gastrointestinal diseases significantly affected OA occurrence; this effect persisted despite adjusting for all covariates in model 3 (odds ratio = 2.01; 95% confidence interval = 1.23-3.3, p = 0.0069) and was confirmed by risk-stratification analysis. The ROC curve and the smooth curve showed that gastrointestinal diseases increased OA risk. Gastrointestinal diseases are significant risk factors for OA, which indicates a potential theoretical basis for OA prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.